Armune Technology
- Commercial Applications -
The initial company focus is on the development of a prostate cancer diagnostic blood test with high sensitivity and specificity. A prostate cancer prognostic blood test to differentiate between indolent and aggressive prostate cancer is also being developed. The technology is also being used for development of lung cancer diagnostic and prognostic tests, and has further potential application for a breast cancer diagnostic test.
The above tests are currently being developed by Armune and the Company will make them available to physicians once the clinical studies have been completed. Check this website periodically for an update.